Prove stocks
CROs, clinical trials, real-world evidence and validation systems that turn discoveries into accepted medicine.
H3 capability map
Prove technologies
Open a technology to understand the capability, evidence framework and every directly mapped public stock.
Full research
Contract Research Organization (CRO)
6 stocks mapped · Open research ↗ Research coming soonFull-Service Clinical Research Organizations (CRO)
0 stocks mapped · Open research ↗ Research coming soonLab Services & National Diagnostic Networks
2 stocks mapped · Open research ↗ Research coming soonPreclinical CRO + CGT manufacturing proxy
1 stock mapped · Open research ↗Prove stock picks
MEDPMedpaceFull-service CRO, biotech-focused
Prove
HOLD○○○○○
○○○○○
$445Research target
8/24/26Last reviewed
↗
FTREFortreaFull-service CRO, spun from Labcorp — turnaround
Prove
WATCH●●○○○
●●○○○
$21.41Research target
8/22/26Last reviewed
↗
IQVIQVIAFull-service CRO + RWD/RWE data moat
Prove
WATCH●●○○○
●●○○○
$248.60Research target
8/6/26Last reviewed
↗
CRLCharles River LaboratoriesPreclinical CRO + CGT manufacturing proxy
Prove
WATCH●●○○○
●●○○○
$234.25Research target
7/8/26Last reviewed
↗
ICLRICONFull-service CRO with FSP model
Prove
WATCH●●○○○
●●○○○
$239Research target
7/8/26Last reviewed
↗
No stock picks match these filters.